Bio & Insurance Information

Dr. Omid Hamid is a medical oncology specialist in Los Angeles, California and he works at several hospitals in the area, including St. John's Health Center and Cedars-Sinai Medical Center. He got his diploma from Keck School of Medicine of USC and did his residency in internal medicine at the University of Southern California - LAC+USC Medical Center, where he also did two fellowships in hematology and medical oncology. The doctor is certified in medical oncology and has an experience of more than 20 years.



Education & Training

Keck School of Medicine of USC

Medical School

University of Southern California - LAC+USC Medical Center

Residency

University of Southern California - LAC+USC Medical Center

Fellowship

Board Certifications

American Board of Internal Medicine - Oncology

Hospitals & Clinics

Cedars-Sinai Medical Center

Languages: English/Spanish

(310) 423-3277

8700 Beverly Blvd

Los Angeles, California 90048

Read More

Providence Saint John's Health Center

Languages: English/Spanish

(310) 829-5511

2121 Santa Monica Boulevard

Santa Monica, California 90404

Read More

Ronald Reagan UCLA Medical Center

Languages: English/Spanish

(310) 825-9111

757 Westwood Plaza

Los Angeles, California 90095

Read More

Publications

Dr. Omid Hamid has contributed to 3 publications.

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.

Hodi, F. S.,Hwu, W. J.,Kefford, R.,Weber, J. S.,Daud, A.,Hamid, O.,Patnaik, A.,Ribas, A.,Robert, C.,Gangadhar, T. C.,Joshua, A. M.,Hersey, P.,Dronca, R.,Joseph, R.,Hil...; J. Clin. Oncol.. 2016 Mar 09.

See more >>

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

Corcoran, R. B.,Atreya, C. E.,Falchook, G. S.,Kwak, E. L.,Ryan, D. P.,Bendell, J. C.,Hamid, O.,Messersmith, W. A.,Daud, A.,Kurzrock, R.,Pierobon, M.,Sun, P.,Cunningham...; J. Clin. Oncol.. 2015 Sep 24.

See more >>

Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.

Flaherty, D. C.,Hoffner, B. W.,Lau, B. J.,Hamid, O.,Faries, M. B.; J Surg Oncol. 2015 Oct 28.

See more >>

Memberships

American Society of Clinical Oncology